logo
Wrong email address or username
Wrong email address or username
Incorrect verification code
back to top
Search tags: renal-denervation-market
Load new posts () and activity
Like Reblog Comment
text 2020-02-18 09:17
Renal Denervation Market Technologies, Latest Devices, Industry Size, Future Trends and Development Strategy Till 2023

Global Renal Denervation Market is expected to rise at a solid CAGR of 40.4% over the 2018-2023 forecast period, with the market’s value rising from USD 200 million in 2017 to USD 2,850 million in 2023.

 

 

The Global Renal Denervation Market is majorly driven by the rising prevalence of hypertension across the world. According to the CDC, the prevalence of hypertension was close to 26% among adults aged 20 years or more in 2000.

 

Global Renal Denervation Market Insights 2020 provides a unique tool for evaluating the Market, highlighting opportunities, and supporting strategic and tactical decision-making. This report recognizes that in this rapidly-evolving and competitive environment, up-to-date Marketing information is essential to monitor performance and make critical decisions for growth and profitability. It provides information on trends and developments, and focuses on Markets and materials, capacities and technologies, and on the changing structure of the Serotonin Supplements Market.

 

Some of the key players operating for the global market analysis are Boston Scientific, Medtronic, ReCor Medical, St. Jude Medical, Cardiosonic, Cordis, Kona Medical, Sound Intervention, and Terumo.

 

Global Renal Denervation Market Research Coverage:

 

  1. Changing market dynamics of the industry
  2. To get a comprehensive overview of the Renal Denervation Market.
  3. Historical, current and projected market size in terms of volume and value
  4. In-depth market segmentation
  5. Competitive landscape

Chapters Included for This Market Study: -

Chapter 1: to describe the Market Introduction, product scope, market overview, market opportunities, market risk, market driving force.

Chapter 2: to analyze the top manufacturers with sales, revenue, and price.

Chapter 3: to display the competitive situation among the top manufacturers, with sales, revenue and market share in Forecasted Time.

Chapter 4: to show the Global Market by regions, with sales, revenue and market share for each region, during the forecast period.

Chapter 5, 6, 7, 8 and 9: to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10: to show the market by type and application, with sales market share and growth rate by type, application, Methodology, Analyst Introduction, Data Source By MRFR

Access Complete Detailed TOC Research Report at https://www.marketresearchfuture.com/reports/renal-denervation-market-6712

 

This report focuses on the global Renal Denervation Market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Renal Denervation Market development in United States, Europe and China.

Market segment by Regions/Countries, this report covers

 

United States

Europe

China

Japan

Southeast Asia

India

Central & South America

About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Source: www.marketresearchfuture.com/reports/renal-denervation-market-6712
Like Reblog Comment
text 2018-08-17 11:54
Renal Denervation Devices Market Opportunity Analysis, 2018-2026

Renal denervation is a catheter-based minimally invasive procedure. It is a therapy carried out by radiofrequency or ultrasound ablation for uncontrolled hypertension. Renal denervation is performed through endovascular catheter-based procedure to treat hypertension, which is beyond medication control. The procedure consists of a catheter that emits radiofrequency energy across multiple electrodes.

 

Click To Continue Reading on Renal Denervation Devices Market

 

Radiofrequency pulse is applied to the renal artery, which causes the wall of artery to ablate, reducing the nerve activity, thereby reducing blood pressure. The progress of catheter-based interventional therapies has yielded impressive results in certifying enhanced blood pressure control in patients with complaints of uncontrolled hypertension, vascular, and cardiovascular diseases.

 

According to the International Journal of Hypertension in 2013, atrial hypertension affects around 24.8% of the global population, posing morbidity and mortality. Rising prevalence of hypertension with inefficient anti-hypertensive medicines, lasting effect of renal denervation, and fast development of renal denervation devices are expected to drive the growth of renal denervation devices market.

 

The market is expected to grow drastically with the FDA approval of Symplicity HTN-4 renal denervation device, owing to its targeted radiofrequency energy delivery, thereby minimizing the potential threat to surrounding tissues. The market for renal denervation devices and associated processes is also driven by advantages such as higher safety, reduced treatment time, permanent effect, and rising incidence of  uncontrolled & treatment-resistant hypertension.

 

Regional segmentation of the global renal denervation devices market by Coherent Market Insights comprises North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. The renal denervation devices market in Europe is considered to be the biggest, owing to the increasing number of drug-resistant hypertension cases and technological advances for manufacturing efficient devices. According to the American Heart Association estimates in 2013, around 33% (nearly 70 million people) of the U.S. adult population suffer from high blood pressure. The rising occurrence of uncontrolled hypertension and increasing FDA approvals for drugs are expected to be the major factors driving market growth in North America in the forecast period.

 

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/798

 

Key Vendors:

Medtronic Plc., St. Jude Medical, ReCor Medical Inc., Boston Scientific Corporation, and Cardiosonic Ltd.

 

About Coherent Market Insights:

 

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

Contact Us:

 

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: sales@coherentmarketinsights.com

Visit our news Website: https://www.coherenttimes.org/

 

More posts
Your Dashboard view:
Need help?